USFDA APPLICATION NUMBER - 21957 / DOSAGE - FOR SUSPENSION, DELAYED RELEASE;ORAL - EQ 20MG BASE/PACKET
Active Ingredient/Active Moiety | ||
Ingredient Name | Basis of Strength | Strength |
---|---|---|
ESOMEPRAZOLE MAGNESIUM(UNII: R6DXU4WAY9) (ESOMEPRAZOLE - UNII:N3PA6559FT) | ESOMEPRAZOLE | 40mg | 40mg | 20mg |
Inactive Ingredients
Ingredient Name | Cardinal Health | Cipla USA Inc. |
---|---|---|
ALCOHOL(3K9958V90M) | ||
ANHYDROUS CITRIC ACID(XF417D3PSL) | ||
ANHYDROUS DEXTROSE(5SL0G7R0OK) | ||
BUTYL ALCOHOL(8PJ61P6TS3) | ||
CROSPOVIDONE(2S7830E561) | ||
D&C RED NO. 28(767IP0Y5NH) | ||
D&C YELLOW NO. 10(35SW5USQ3G) | ||
FD&C BLUE NO. 1(H3R47K3TBD) | ||
FD&C RED NO. 40(WZB9127XOA) | ||
FERRIC OXIDE YELLOW(EX438O2MRT) | ||
GELATIN(2G86QN327L) | ||
GLYCERYL MONOSTEARATE(230OU9XXE4) | ||
HYDROXYPROPYL CELLULOSE (1600000 WAMW)(RFW2ET671P) | ||
HYDROXYPROPYL CELLULOSE (TYPE H)(RFW2ET671P) | ||
HYPROMELLOSE 2910 (15 MPA.S)(36SFW2JZ0W) | ||
HYPROMELLOSES(3NXW29V3WO) | ||
ISOPROPYL ALCOHOL(ND2M416302) | ||
MAGNESIUM STEARATE(70097M6I30) | ||
METHACRYLIC ACID AND ETHYL ACRYLATE COPOLYMER(NX76LV5T8J) | ||
METHACRYLIC ACID(1CS02G8656) | ||
POLYETHYLENE GLYCOLS(3WJQ0SDW1A) | ||
POLYSORBATE 80(6OZP39ZG8H) | ||
POTASSIUM SORBATE(1VPU26JZZ4) | ||
POVIDONES(FZ989GH94E) | ||
SODIUM HYDROXIDE(55X04QC32I) | ||
TALC(7SEV7J4R1U) | ||
TITANIUM DIOXIDE(15FIX9V2JP) | ||
TRIETHYL CITRATE(8Z96QXD6UM) | ||
WATER(059QF0KO0R) | ||
XANTHAN GUM(TTV12P4NEE) |
LOOKING FOR A SUPPLIER?